{"nct_id":"NCT01132664","title":"Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer","status":"TERMINATED","status_verified_date":"2016-08","start_date":"2010-05","start_date_type":null,"primary_completion_date":"2014-08","primary_completion_date_type":"ACTUAL","completion_date":"2014-08","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}